Carboplatin-Paclitaxel-Pembrolizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Carboplatin-Paclitaxel-Pembrolizumab, covering 2021-08-27 to 2021-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer [Phase 2]